Original Research

Reduced use of erythropoiesis-stimulating agents and intravenous iron with ferric citrate: a managed care cost-offset model

Mutell R, Rubin JL, Bond TC, Mayne T

International Journal of Nephrology and Renovascular Disease 2013, 6:79-87

Published Date: 30 April 2013